Literature DB >> 10970687

Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer.

A Grothey1, R Hashizume, A A Sahin, P D McCrea.   

Abstract

Loss of hormone receptor (HR) status in breast carcinomas is associated with increased tumour cell motility and invasiveness. In an immunohistological study of 58 primary breast cancers, oestrogen (ER) and progesterone (PR) receptor levels were inversely correlated with the expression of fascin, an actin-bundling protein associated with cell motility (P< 0.0001 and P = 0.0019, respectively). In addition, fascin was preferentially expressed in non-diploid tumours (P = 0.03). In summary, the upregulation of fascin in HR-negative breast cancers may contribute to their more aggressive behaviour. Copyright 2000 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10970687      PMCID: PMC2374674          DOI: 10.1054/bjoc.2000.1395

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  41 in total

1.  Negative association between GATA3 and fascin could predict relapse-free and overall survival in patients with breast cancer.

Authors:  Kyueng-Whan Min; Dong-Hoon Kim; Sung-Im Do; Seoung Wan Chae; Kyungeun Kim; Jin Hee Sohn; Jung-Soo Pyo; Hyun Joo Lee; Dong Hyun Kim; Sukjoong Oh; Seon Hyeong Choi; Yong Lai Park; Chan Heun Park; Eun-Kyung Kim; Mi Jung Kwon; Jinwon Seo; Kyoung Min Moon
Journal:  Virchows Arch       Date:  2015-12-30       Impact factor: 4.064

2.  Fascin and CK4 as biomarkers for esophageal squamous cell carcinoma.

Authors:  Mikiko Takikita; Nan Hu; Jian-Zhong Shou; Carol Giffen; Quan-Hong Wang; Chaoyu Wang; Stephen M Hewitt; Philip R Taylor
Journal:  Anticancer Res       Date:  2011-03       Impact factor: 2.480

3.  Fascin-1 knock-down of human glioma cells reduces their microvilli/filopodia while improving their susceptibility to lymphocyte-mediated cytotoxicity.

Authors:  Neil T Hoa; Lisheng Ge; Kate L Erickson; Carol A Kruse; Andrew N Cornforth; Yurii Kuznetsov; Alex McPherson; Filippo Martini; Martin R Jadus
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

4.  Fascin expression predicts an aggressive clinical course in patients with advanced breast cancer.

Authors:  Kyueng-Whan Min; Seoung Wan Chae; Dong-Hoon Kim; Sung-Im DO; Kyungeun Kim; Hyun Joo Lee; Jin Hee Sohn; Jung-Soo Pyo; Dong Hyun Kim; Sukjoong Oh; Seon Hyeong Choi; Yong Lai Park; Chan Heun Park
Journal:  Oncol Lett       Date:  2015-05-08       Impact factor: 2.967

5.  Molecular mechanism of fascin function in filopodial formation.

Authors:  Shengyu Yang; Fang-Ke Huang; Jianyun Huang; Shuai Chen; Jean Jakoncic; Alejandra Leo-Macias; Ruben Diaz-Avalos; Lin Chen; J Jillian Zhang; Xin-Yun Huang
Journal:  J Biol Chem       Date:  2012-11-26       Impact factor: 5.157

6.  miR-145 suppresses breast cancer cell migration by targeting FSCN-1 and inhibiting epithelial-mesenchymal transition.

Authors:  Hong Zhao; Xing Kang; Xuefeng Xia; Like Wo; Xidong Gu; Yuanyuan Hu; Xiaohong Xie; Helena Chang; Lihua Lou; Xuning Shen
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

7.  Fascin expression in human embryonic, fetal, and normal adult tissue.

Authors:  Fa-Ren Zhang; Li-Hua Tao; Zhong-Ying Shen; Zhuo Lv; Li-Yan Xu; En-Min Li
Journal:  J Histochem Cytochem       Date:  2007-11-12       Impact factor: 2.479

8.  The role of fascin in the migration and invasiveness of malignant glioma cells.

Authors:  Jeong Hyun Hwang; Christian A Smith; Bodour Salhia; James T Rutka
Journal:  Neoplasia       Date:  2008-02       Impact factor: 5.715

9.  Migrastatin analogues target fascin to block tumour metastasis.

Authors:  Lin Chen; Shengyu Yang; Jean Jakoncic; J Jillian Zhang; Xin-Yun Huang
Journal:  Nature       Date:  2010-04-15       Impact factor: 49.962

10.  Proteomic analysis of exosomes secreted by human mesothelioma cells.

Authors:  Joost P J J Hegmans; Martin P L Bard; Annabrita Hemmes; Theo M Luider; Monique J Kleijmeer; Jan-Bas Prins; Laurence Zitvogel; Sjaak A Burgers; Henk C Hoogsteden; Bart N Lambrecht
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.